Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image
- PMLiVE

Pharmaceutical Market Europe – Febuary 2015

March's PME features an extended focus on the changes to England’s Cancer Drugs Fund, exclusive interviews with AstraZeneca's Lisa Anson and J&J's Sabine Dandiguian and we look at adherence and...

- PMLiVE

Pharmaceutical Market Europe – January 2015

In PME’s first issue of 2015 we hear from Dr Vytenis Andriukaitis and thought leadership from Uta Kemmerich-Keil, consumer health head at Merck KGaA.

- PMLiVE

Pharmaceutical Market Europe – December 2014

In the December issue of PME we hear from Patrick Vink, general manager of international business for Cubist

- PMLiVE

Pharmaceutical Market Europe – November 2014

In the November issue of PME we hear from Celgene’s Tuomo Pätsi about company culture, marketing and access

- PMLiVE

Pharmaceutical Market Europe – October 2014

In the October issue of PME we hear from Novo Nordisk’s Klaus Henning Jensen, who explains how the medical affairs function has had to change to become more market-focused.

- PMLiVE

Pharmaceutical Market Europe – September 2014

In this issue we hear from UCB’s chief executive Roch Doliveux, EFPIA’s Richard Bergstöm and Publicis’ Sam Welch

- PMLiVE

Pharmaceutical Market Europe – July/August 2014

In this issue we talk with Anssi Pulkkinen from Roche Diagnostics, Finland

- PMLiVE

Pharmaceutical Market Europe – June 2014

Allergan’s Paul Navarre and Paul Boland tell us about creating a culture of growth and we take a look at the Sunshine Act, diabetes and marketing in China and the...

- PMLiVE

Pharmaceutical Market Europe – May 2014

AstraZeneca’s Susan Galbraith - the company’s VP of oncology talks about AZ’s pipeline prospects

- PMLiVE

Pharmaceutical Market Europe – April 2014

MSD’s Bruno Strigini - the company’s president, Europe and Canada discusses adapting to a new market reality

- PMLiVE

Pharmaceutical Market Europe – March 2014

Mundipharma's Georg Toufar - the company’s chief marketing officer on the benefits of having a smaller, more concentrated focus

- PMLiVE

Pharmaceutical Market Europe – February 2014

Ferring’s president explains his company's approach to ‘controlled entrepreneurship’